PETER ROST: PHARMA MARKETING EXPERT WITNESS. AWP, MEDICAL DEVICE EXPERT.: Quote of the day: Abraxis BioScience
screen2largeMM

Dr. Rost provides services as a pharmaceutical marketing expert witness. For more info see: Drug Expert Witness. Dr. Peter Rost email. Copyright © 2006-2013 InSync Communication. All rights reserved. Terms of use agreement, privacy policy and the computer fraud and abuse act.
.

PETER ROST: PHARMA MARKETING EXPERT WITNESS. AWP, MEDICAL DEVICE EXPERT.

Peter Rost, M.D., is a former Pfizer Marketing Vice President providing services as a medical device and drug expert witness and pharmaceutical marketing expert. Judge Sanders: "The court agrees with defendants' view that Dr. Rost is a very adept and seasoned expert witness." He is also the author of Emergency Surgery, The Whistleblower and Killer Drug. You can reach him on rostpeter (insert symbol) hotmail.com. Please read the terms of use agreement and privacy policy for this blog carefully.

Quote of the day: Abraxis BioScience

AstraZeneca's "Zubegate" is moving over to Abraxis BioScience's message board on CafePharma.

This appears to be a comment by an Abraxis BioScience sales rep. If so it supports what AstraZeneca's "Fantastic 7" have claimed:

"If I were a MSL or DSM, I will be very concerned because they are all complicit in off-label promotions. I have been told many times by my manager to use MSL to promote off-label and NEVER to put anything on email or in writing.

AZ counterpart received the same instruction. It is time we unite and do what the Gang of Seven at AZ has done. We should be policing our MSL, DSM, BF, CM, JH, RAMs, and make sure that we document and report all illegal activities. I still don't know the basis for my ridiculously high sales target!

Today the Abraxis 300 is born to fight corruption, illegal marketing, offlabel promotions, sex discrimination and incompetent incompetence of the ABBI management."

To the "Abraxis 300" sales reps: Write rostpeter@hotmail.com with more tips and information. If credible, it will be published.

Labels:

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home